# TelosRX vs VelvetRX: GLP-1 Weight Loss Compared **By TelosRX Editorial Team** ยท 2026-08-18 VelvetRX advertises that you can see if you qualify for weight loss medication in under two minutes. Their pricing is published openly, which is more than several competitors manage, so a straight comparison is possible. This article covers what each company charges, and a few things on the VelvetRX site that are worth understanding before you enter your details. The short answer Both companies publish their prices. telos rx is lower on all three comparable products: semaglutide $99 against $139, tirzepatide $139 against $179, and oral GLP-1 $129 against $189. VelvetRX's compounded medication disclosure is hidden on mobile screens, so most visitors arriving from a phone ad never see it. [Check your eligibility](https://start.telosrx.com/start-online-visit/weightloss) ## Pricing, side by side VelvetRX deserves credit for putting prices on the homepage rather than behind a quiz. They offer three products: injectable semaglutide from $139 a month, injectable tirzepatide from $179, and an oral GLP-1 from $189. telos rx publishes the equivalent three at $99, $139 and $129, plus a microdosed tirzepatide at $116 that VelvetRX does not offer. Product VelvetRX telos rx Injectable semaglutide From $139/month From $99/month Injectable tirzepatide From $179/month From $139/month Oral / needle-free GLP-1 From $189/month From $129/month Microdosed tirzepatide Not offered From $116/month Compounded disclosure on mobile Hidden below 768px Shown at every screen size Published success-rate claim 98% program success rate No success-rate claim made Figures for both companies reflect publicly published pricing as of this article's publish date and are subject to change. ## The disclosure that disappears on a phone VelvetRX does carry the necessary compounded medication disclosure. It reads, in part, that compounding drugs are not FDA-approved or evaluated for safety, effectiveness or quality by the FDA, that testimonials are paid, that customer results have not been independently verified, and that stopping treatment has been shown to result in weight regain. That is a thorough and honest paragraph. The problem is where it lives. The paragraph carries styling that hides it on screens narrower than 768 pixels and shows it only from tablet width upward. We checked the same page at two sizes: at 375 pixels wide, a standard phone, the element computes to display none and the text does not appear on the page at all. At 1280 pixels it renders, in 11 pixel grey type. Search and social ads for GLP-1 medication reach a heavily mobile audience, which means a large share of VelvetRX visitors are shown the marketing claims without the paragraph that qualifies them. We are describing what the page does, not asserting intent. It may well be an oversight in a responsive layout rather than a decision. Either way, it is worth knowing that the fine print you would want to read is not on the version of the page most people see. ## Claims worth reading twice The VelvetRX homepage states a 98% program success rate and a 15 to 20% average body weight reduction among members. Neither figure is sourced, and the site's own disclosure says customer results have not been independently verified. A 98% success rate would be a remarkable result for any weight management intervention. Separately, the page cites a real clinical finding: after 68 weeks, participants on once-weekly semaglutide lost an average of 14.9% of body weight against 2.4% on placebo. That result comes from a trial of the branded, FDA-approved product. It is presented near the heading "Lose up to 14.9% of your body weight in three simple steps," which invites the reader to apply a branded-drug trial result to a compounded preparation that was not part of that trial. Compounded medication is not required to demonstrate equivalence to the approved product, so trial figures for the brand do not transfer. telos rx does not publish a success rate or an average weight loss figure, because we cannot substantiate one for a compounded product and we would rather say nothing than say something unverifiable. ## Two things that look unfinished The homepage FAQ has eleven questions. Every one of them returns the identical answer: "Our care team will guide you with personalized support based on your health profile and treatment plan." That includes the questions asking whether GLP-1 can be used while pregnant, breastfeeding or trying to conceive, how cancellations and refunds work, and whether their pharmacies are FDA-compliant. Those are exactly the questions a reader most needs answered, and the pregnancy question in particular carries real clinical weight. The testimonial carousel is also unusual. It presents eight member stories under headings like Month 1, Month 3 and Month 10, and every single one is attributed to the same person: Susan G., San Antonio, TX, 24. More oddly, the quotes are not about weight loss at all. They describe skin texture, glow and fine lines, and two of them name GHK-Cu, a copper peptide used for skin, on a page selling GLP-1 weight loss medication. That reads like testimonial copy from a different product left in place. > None of this means VelvetRX cannot deliver medication. It means the public page is not currently a reliable place to learn what you are buying, and the paragraph that would tell you is switched off on phones. ## Which one fits you On the numbers, telos rx is lower on every product the two companies both sell, and adds a microdosed option VelvetRX does not carry. If you are weighing them up, the fairest thing you can do is open the VelvetRX homepage on a desktop browser rather than your phone, read the grey paragraph at the bottom, and then decide. ## Frequently asked questions How much does VelvetRX cost? Their homepage lists injectable semaglutide from $139 a month, injectable tirzepatide from $179 and an oral GLP-1 from $189. telos rx publishes $99, $139 and $129 for the equivalent three. Does VelvetRX disclose that its medication is not FDA-approved? Yes, but only on larger screens. The paragraph is styled to be hidden below 768 pixels, so on a standard phone it does not render at all. On desktop it appears in small grey type at the foot of the page. Is the 98% success rate verified? No source is given for it. VelvetRX's own disclosure states that customer results have not been independently verified, which sits awkwardly beside a specific 98% figure. Can compounded semaglutide be expected to match the 14.9% trial result? That figure comes from a trial of the branded, FDA-approved medication. Compounded preparations are not required to demonstrate equivalence to the approved product and were not studied in that trial, so the result should not be read as a promise for a compounded version. Is telos rx cheaper than VelvetRX? On published pricing, yes, on all three shared products: $40 a month less on semaglutide, $40 less on tirzepatide and $60 less on the needle-free oral option. Compounded medications, including semaglutide and tirzepatide, are not FDA-approved. A prescription requires review and approval by a licensed provider, approval is not guaranteed, and individual results vary. All observations about VelvetRX's website reflect what was publicly visible on their site as of this article's publish date and may change. Pricing for both companies is subject to change. [Start your private evaluation](https://www.telosrx.com) --- > Source: [Telos RX](https://www.telosrx.com/blogs/glp1/telosrx-vs-velvetrx)